Article
Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the…
Degenerative Neurological and Neuromuscular Disease · 2022 · Ruggieri S, Quartuccio ME, Prosperini L
Key facts
| Title | Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data |
|---|---|
| First author | Ruggieri S, Quartuccio ME, Prosperini L |
| Journal | Degenerative Neurological and Neuromuscular Disease |
| Published | Mar 22, 2022 |
| DOI | 10.2147/DNND.S313825 |
| Devices mentioned | K951631, K980521 |
| Product codes mentioned | KXT, LFM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1